Search for: "Predictive Therapeutic LLC"
Results 1 - 20
of 36
Sort by Relevance
|
Sort by Date
3 May 2024, 6:38 am
For example, according to the fact pattern, the data provided by Raghu was from a well-known cancer-related compound data set provided by the National Cancer Institute, i.e. it was not a new source of data.[19] Furthermore, the DNN that performed the processing was a ready-to-use system that can predict the strength of interaction between drug-target pairs, i.e. there was no new technique for analyzing the provided data.[20] Based on these two factors, it appears our limitation contains… [read post]
26 Feb 2024, 9:50 pm
TA Instruments-Waters LLC (Fed. [read post]
29 Dec 2023, 3:26 am
TTABlog comment: Any predictions? [read post]
16 May 2023, 7:51 am
The Federal Circuit concurred with the district court finding that the improved stability was a difference in “degree” and a predictable effect of altering PVP content. [read post]
1 Feb 2023, 9:05 pm
Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
6 Jan 2023, 9:01 am
Overhauser Law Offices LLC, the publisher of this site, assists with US and foreign patent searches, patent applications and assists with enforcing patents via infringement litigation and licensing. [read post]
5 Oct 2022, 4:11 am
CGS Administrators, LLC (CGS). [read post]
17 Jul 2022, 5:00 am
GlaxoSmithKline LLC, SCT Docket No. 22-37 (2022). [read post]
19 Mar 2022, 2:09 pm
Such an estimate, however, does not necessarily give a realistic prediction of the risk. [read post]
7 Dec 2021, 6:37 pm
by Dennis Crouch Teva Pharmaceuticals, LLC v. [read post]
7 Dec 2021, 8:33 am
SIPCO, LLC v. [read post]
16 Mar 2021, 6:00 am
To the Open Source Hardware (OSHW) community, the Federal Circuit’s October opinion in the ongoing appeal of GlaxoSmithKline LLC v. [read post]
19 Feb 2021, 2:28 am
Sanofi, Aventisub LLC et al., ___ F.3d ___, No. 2020-1074 (Fed. [read post]
Guest Post: Halliburton II Price Impact Defenses Can Limit Severity on Deficient Exchange Act Claims
12 Jan 2021, 2:19 pm
Predictability should make navigating settlement easier. [read post]
31 Dec 2020, 3:06 am
"]January 19, 2021 - 11 AM: In re Spark Therapeutics, Inc., Serial No. 87614019 [Section 2(d) refusal of SPARK THERAPEUTICS GENERATION PATIENT SERVICES for, inter alia, providing information for patients, families and health care providers about health care insurance coverage and insurance reimbursement programs [THERAPEUTICS and PATIENT SERVICES disclaimed], in view of the registered mark SPARQ & Design for "Providing health information services, namely,… [read post]
8 Jun 2020, 10:00 pm
Now, underINO Therapeutics, LLC v. [read post]
9 Mar 2020, 1:21 pm
· Molly Burich, Director of Public Policy, Boehringer Ingelheim · Surya Singh, President, Singh Healthcare Advisors, LLC Moderated Panel Discussion Meredyth Andrus, Attorney, Health Care Division, Bureau of Competition, FTC Does the designation of interchangeability still have value in the US? [read post]
15 Oct 2019, 5:27 pm
In OSI Pharmaceuticals, LLC v. [read post]
29 Mar 2019, 3:13 am
April 9, 2019 - 1 PM: OnePoint Patient Care, LLC v. [read post]
1 May 2018, 6:50 am
But the solutions, here, were simple and predictable. [read post]
